Jonathan Craig Bowman, MD | |
355 N Main St, Kanab, UT 84741-3260 | |
(435) 644-4100 | |
(435) 644-3366 |
Full Name | Jonathan Craig Bowman |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 24 Years |
Location | 355 N Main St, Kanab, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619047362 | NPI | - | NPPES |
107023013101 | Other | UT | SELECT HEALTH |
D5247 | Medicaid | UT | |
53498121200001 | Other | UT | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 5349812 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Zion's Way Home Health | St george, UT | Home health agency |
Zion's Way Hospice | St george, UT | Hospice |
Zion's Way Hospice | Page, AZ | Hospice |
Kane County Hospital | Kanab, UT | Hospital |
Garfield Memorial Hospital | Panguitch, UT | Hospital |
Dixie Regional Medical Center | St george, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
The Texas Senate's Health and Human Services Committee on Tuesday voted 5-1 to approve a bill (S.B. 188) that would protect needle-exchange programs run by local health departments, the AP/Houston Chronicle reports.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
› Verified 2 days ago
Entity Name | Central Utah Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
The Texas Senate's Health and Human Services Committee on Tuesday voted 5-1 to approve a bill (S.B. 188) that would protect needle-exchange programs run by local health departments, the AP/Houston Chronicle reports.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
› Verified 2 days ago
Entity Name | Kane County Human Resource Special Service District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043380991 PECOS PAC ID: 5092603316 Enrollment ID: O20040309000209 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
The Texas Senate's Health and Human Services Committee on Tuesday voted 5-1 to approve a bill (S.B. 188) that would protect needle-exchange programs run by local health departments, the AP/Houston Chronicle reports.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jonathan Craig Bowman, MD 1055 N 500 W, Attn: Credentialing, Provo, UT 84604-3305 Ph: (801) 354-8225 | Jonathan Craig Bowman, MD 355 N Main St, Kanab, UT 84741-3260 Ph: (435) 644-4100 |
News Archive
A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.
Before launching a program to promote resilience and prevent burnout among staff nurses, hospitals and healthcare organizations should identify barriers and concerns relevant to their own clinicians, according to an article in AACN Advanced Critical Care.
The Texas Senate's Health and Human Services Committee on Tuesday voted 5-1 to approve a bill (S.B. 188) that would protect needle-exchange programs run by local health departments, the AP/Houston Chronicle reports.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
› Verified 2 days ago
Bryson J Hollingshead, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100 Fax: 435-644-3366 | |
Darin Dale Ott, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100 Fax: 435-644-3366 | |
Dr. Lance O. Allen, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100 Fax: 435-644-3366 | |
Dr. David Michael Salter, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 355 N Main St, Kanab, UT 84741 Phone: 435-644-4100 Fax: 435-644-3366 |